Device including altered microorganisms, and methods and systems of use

US8682619B2 · kind B2 · utility

Assignee

• THE INVENTION SCIENCE FUND I, LLC · US

Inventors

• Dario G. Amodei · Princeton, US
• Mahalaxmi Gita Bangera · Renton, US
• Xiaoyan Robert Bao · Cambridge, US
• Anna Bershteyn · Seattle, US
• Brett Bethke · Arlington, US
• Philip A. Eckhoff · Bellevue, US
• Kevin Michael Esvelt · Cambridge, US
• Kyle B. Gustafson · Lausanne, CH
• Edward K.Y. Jung · Bellevue, US
• William Michael Kaminsky · Alexandria, US
• Jordin T. Kare · Seattle, US
• Lily Yvonne Kim · Brookline, US
• Eric C. Leuthardt · Chesterfield, US
• Erez Lieberman · Cambridge, US
• Ankur Moitra · Cambridge, US
• Christopher Somogyi · Woodinville, US
• Clarence T. Tegreene · Bellevue, US
• Lowell L. Wood, JR. · Bellevue, US
• Jeremiah Zartman · Montgomery, US

Key dates

• Filing date: May 28, 2010
• Grant date: Mar 25, 2014
• Expiry date: Jul 4, 2031

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A90/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Devices, methods, and systems are described for administration to at least one biological tissue of at least one device including at least one altered microorganism. In an embodiment, the altered microorganism includes at least one nucleic acid construct encoding at least one therapeutic agent.